Research

Zacks Small Cap Analysis – PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Via Scientific Trials to Enhance Surgical Outcomes, Improve Remedy Efficacy, Reduce Facet Results – Model Slux

by
Zacks Small Cap Analysis – PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Via Scientific Trials to Enhance Surgical Outcomes, Improve Remedy Efficacy, Reduce Facet Results – Model Slux

By M. Marin NASDAQ:PYPD Revolutionary Drug Supply Platform (PLEX Know-how) PolyPid Ltd. (NASDAQ:PYPD) is a late medical stage biopharma firm centered on creating domestically administered, prolonged-release therapeutics utilizing its proprietary Polymer-Lipid Encapsulation matriX (PLEX) know-how, which permits the managed supply of medicines straight on the surgical web site over prolonged durations starting from days to … Read more

Zacks Small Cap Analysis – TELO Produces Outcomes with Thrilling AMD Implications – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescription drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm growing a product designed to elongate the DNA’s protecting telomere caps. Beforehand reported preclinical checks have proven proof that Telomir-1, the corporate’s main remedy, can lengthen telomeres and preliminary animal testing illustrates the potential … Read more

Zacks Small Cap Analysis – TRC: Board Composition Has Modified Over Previous Yr; Half the Administrators are New – Model Slux

by

By M. Marin NYSE:TRC Shareholders ship one other clear message that change is required TRC shareholders re-elected a lot of the firm’s board nominees however added newcomer Andrew Dakos as a substitute of reelecting Michael Winer, who had been a director for twenty-four years. Andrew Dakos was a part of an activist investor … Read more

Zacks Small Cap Analysis – AZTR: ATR-04 Trial to Dose 1st Affected person Mid-2025 – Model Slux

by
Zacks Small Cap Analysis – AZTR: ATR-04 Trial to Dose 1st Affected person Mid-2025 – Model Slux

By John Vandermosten, CFA NYSE:AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2025 ends in a Could 13th press launch sharing monetary outcomes and offering a enterprise replace. 12 months so far, the corporate has offered posters at a number of scientific conferences, entered into a purchase order settlement to lift … Read more

Zacks Small Cap Analysis – CXW: Imagine CXW is Effectively-Positioned for Additional Occupancy Will increase – Model Slux

by
Zacks Small Cap Analysis – CXW: Imagine CXW is Effectively-Positioned for Additional Occupancy Will increase – Model Slux

By M. Marin NYSE:CXW READ THE FULL CXW RESEARCH REPORT Reactivating idled services, as demand for occupancy is anticipated to rise CoreCivic (NYSE:CXW) reported 1Q25 compensated occupancy of 77.0%, up from 75.2% in 1Q24. Importantly, CXW is within the means of reactivating them, in addition to one different idled facility. ICE is searching for to … Read more

x